Vaccizone
Pre-clinicalVaccizone is developing next generation antigen delivery and vaccine technologies for human and animal diseases based on its novel ASC technology. We are building a platform that changes the vaccine and treatment development paradigm for preventable diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.7M
About
Vaccizone is developing next generation antigen delivery and vaccine technologies for human and animal diseases based on its novel ASC technology. We are building a platform that changes the vaccine and treatment development paradigm for preventable diseases.
Drug Delivery
Funding History
2Total raised:$3.7M
Grant$1.2MSep 15, 2020
Seed$2.5MMay 15, 2019